A Phase 1 interventional study of aspirin versus clopidogrel in Transient Ischemic Attack, Stroke and Aspirin, sponsored by University of California, San Diego. Withdrawn at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-08-02.
Sponsored by University of California, San Diego · Phase 1, Interventional, and Prevention
Pilot study of continuing aspirin versus switching to clopidogrel after stroke or transient ischemic attack.
Pilot study of continuing aspirin versus switching to clopidogrel after stroke or transient ischemic attack.
7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.
Browse Stroke studies →University of California, San Diego is the lead sponsor of 958 studies on the registry; 191 are open to participants now.
Of its 110 completed or terminated interventional studies of FDA-regulated products, 70 (64%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
mRS at three months.
Incidence of stroke at three months, bleeding events.
This study is withdrawn, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, San Diego